CLINICAL_TRIALS
trial_result
· 2021-04-27
Clinical Trial Update: Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy [Phase 2]
Summary
Phase 2 clinical trial evaluating emixustat hydrochloride in proliferative diabetic retinopathy has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kubota Vision Inc. | Conditions: Proliferative Diabetic Retinopathy | Phase 2 | Status: COMPLETED | Results posted: 2021-04-27